Application of antisense oligonucleotide drugs in amyotrophic lateral sclerosis and Huntington’s disease
Abstract Amyotrophic lateral sclerosis (ALS) and Huntington’s disease (HD) are diverse in clinical presentation and are caused by complex and multiple factors, including genetic mutations and environmental factors. Numerous therapeutic approaches have been developed based on the genetic causes and p...
Saved in:
Main Authors: | Kaili Ou, Qingqing Jia, Dandan Li, Shihua Li, Xiao-Jiang Li, Peng Yin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Translational Neurodegeneration |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40035-025-00466-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Dysphagia in Amyotrophic Lateral Sclerosis
by: Xiao QIU, et al.
Published: (2017-02-01) -
Exploring precision therapeutics: computational design of antisense oligonucleotides targeting AXL gene transcripts in multiple sclerosis treatment management
by: Bhargav Shreevatsa, et al.
Published: (2025-02-01) -
Associations of cachexia and frailty with amyotrophic lateral sclerosis
by: Tracy L. Peters, et al.
Published: (2025-02-01) -
Antisense oligonucleotides for the arterial hypertension mechanisms study and therapy
by: L. O. Klimov, et al.
Published: (2018-04-01) -
In vivo efficacy and safety of systemically administered serinol nucleic acid-modified antisense oligonucleotides in mouse kidney
by: Toshiki Tsuboi, et al.
Published: (2025-03-01)